The Economic Toll of COVID-19 and Long COVID: A Global Crisis in Productivity and Workforce Health

COVID-19’s impact on global health has been severe, but its long-term economic effects are just beginning to emerge. Economists, insurance companies, and banks are now studying the substantial costs associated with both acute COVID-19 infections and long COVID, a condition where symptoms linger for months or even years. These lingering effects are hitting economies hard, with significant losses in productivity, increased health care expenses, and the economic burden of an incapacitated workforce.

Here, we’ll explore how COVID-19 and long COVID are affecting work time, productivity, and economic stability in America and worldwide, drawing on insights from leading economists and financial institutions.

1. Lost Work Time and Decreased Productivity

COVID-19 has directly impacted workforce availability due to lost work time from infections, quarantine periods, and recovery. A study from the National Bureau of Economic Research found that COVID-19 absenteeism, on average, leads to a 20% increase in missed workdays across various sectors. With surges in cases due to new variants, these lost workdays accumulate quickly, creating an ongoing drain on productivity.

Long COVID’s Contribution to Lost Productivity

Long COVID further complicates productivity, as affected individuals often experience debilitating symptoms like fatigue, shortness of breath, and brain fog. According to research by the Brookings Institution1https://www.brookings.edu/articles/new-data-shows-long-covid-is-keeping-as-many-as-4-million-people-out-of-work/, nearly 16 million working-age Americans may suffer from long COVID, with an estimated 2-4 million people unable to work as a result. This loss alone is estimated to cost the U.S. economy between $170 billion and $230 billion annually in lost wages, not including the broader economic impact of reduced consumer spending and lower tax revenue.

Globally, the impact is equally severe. The World Health Organization (WHO) estimates that over 17 million people in Europe alone may be affected by long COVID2https://www.who.int/europe/news-room/13-09-2022-at-least-17-million-people-in-the-who-european-region-experienced-long-covid-in-the-first-two-years-of-the-pandemic–millions-may-have-to-live-with-it-for-years-to-come. These numbers suggest a significant, sustained decrease in global workforce productivity, especially as long COVID symptoms can persist indefinitely, preventing many from returning to full-time employment.

2. Reduced Cognitive Function and Brain Fog

Long COVID’s impact on cognitive function—often referred to as “brain fog”—is one of the most concerning symptoms from an economic perspective. Brain fog impairs memory, focus, and problem-solving abilities, all of which are essential to most jobs. The British Medical Journal published a study indicating that long COVID patients frequently report cognitive difficulties lasting well over a year after initial infection. The impact of the reduced ability to function affects all industries where heightened senses and reflexes are literally life saving. This includes pilots, drivers, quality assurance in manufacturing, and so many more.

Impacts on High-Skilled Sectors

High-skill industries that rely on knowledge workers, such as finance, technology, and healthcare, are particularly vulnerable to productivity losses due to cognitive impairment. Employees who can’t perform at their previous levels may require additional support, training, or temporary replacements. This decreased efficiency reduces overall productivity and puts pressure on teams to meet pre-pandemic performance standards.

In the U.S. alone, economists from Harvard University and the University of California, Berkeley, estimate that cognitive impairment in long COVID patients could result in a long-term loss of up to 1.5% of GDP. For a $25 trillion economy, this translates into $375 billion lost annually, a figure that compounds with each year as more workers experience prolonged cognitive effects from COVID-19.

3. Long-Term Healthcare Costs and Insurance Implications

The cost of healthcare for individuals with long COVID presents yet another economic burden. Insurance companies are facing increased claims as people with long COVID symptoms require ongoing medical care. Treatments for long COVID can include regular physician visits, diagnostic testing, rehabilitation services, and prescription medications, all of which place significant pressure on insurance systems.

Rising Insurance Premiums

Insurance companies are passing some of these costs onto consumers. According to the Kaiser Family Foundation, health insurance premiums in the U.S. have seen a gradual rise in recent years, partially due to increased healthcare demands from COVID-19 and long COVID patients. Higher premiums affect both employers, who provide health insurance, and employees, who pay a portion of these premiums. Globally, many healthcare systems, especially in developing countries, are strained to accommodate these prolonged medical needs.

The Role of Disability Insurance

For those unable to return to work, disability claims are on the rise. The Social Security Administration (SSA) in the U.S. has reported a significant increase in disability claims attributed to long COVID, putting additional strain on government funds allocated for disability insurance. This increase in claims could lead to adjustments in disability insurance policy costs, making it more expensive for companies to provide coverage to their employees.

4. Broader Economic Consequences

The economic impact of COVID-19 and long COVID extends beyond productivity and healthcare into the broader economy. The lost earnings and reduced spending power of affected individuals influence overall economic demand. The knock-on effects of a reduced labor force can impact industries such as retail, hospitality, and real estate, as individuals facing long-term health issues often reduce discretionary spending.

Supply Chain and Inflation Pressures

Long COVID-related labor shortages also impact supply chains and contribute to inflation. With fewer workers available to produce, transport, and sell goods, shortages become more frequent, further driving up costs. Sectors such as manufacturing and shipping are particularly vulnerable, as workforce shortages slow production timelines, delay deliveries, and contribute to supply chain bottlenecks.

Global Financial Markets

Banks and financial institutions are watching these trends closely, as reduced productivity, rising healthcare costs, and increased insurance claims all present economic risks. JPMorgan Chase and Goldman Sachs have both warned of potential downgrades in economic growth forecasts if COVID-19 remains a persistent issue. Economists from these institutions highlight the impact of decreased labor participation, increased inflation, and weakened consumer demand, all of which threaten global financial stability.

5. Addressing the Economic Toll: Solutions and Future Steps

Recognizing the economic strain of COVID-19 and long COVID, many companies and governments are beginning to address the problem through policies and support programs:

  • Flexible Work Policies: Some companies are offering flexible work options, such as remote or hybrid work arrangements, to accommodate long COVID sufferers. Flexible schedules can help employees with fluctuating symptoms maintain employment.
  • Government Support and Funding for Long COVID Research: Governments worldwide are investing in research on long COVID treatments, as effective therapies could alleviate symptoms, enabling more people to return to work. The U.S. government, for instance, has allocated billions of dollars for long COVID research through agencies like the National Institutes of Health (NIH).
  • Employee Health and Wellness Programs: Employers are increasingly incorporating wellness programs that offer physical therapy, mental health support, and other health resources to help long COVID patients manage their symptoms.
  • Insurance Reforms: To offset the costs of long COVID care, policymakers and insurance providers are considering reforms that could help lower premiums and spread the financial burden of COVID-19 healthcare costs.

Final Thoughts

The economic impact of COVID-19 and long COVID is profound and far-reaching, affecting everything from individual productivity to global economic growth. Reduced labor participation, higher healthcare costs, and a decrease in cognitive functioning all contribute to an ongoing economic strain. Without effective treatment options, the effects of long COVID will continue to reverberate through the workforce, impacting productivity, public health, and economic stability on a global scale.

Addressing these challenges will require coordinated efforts from governments, financial institutions, healthcare providers, and employers. By prioritizing support for long COVID sufferers, investing in research, and enacting flexible policies, we can begin to mitigate the economic consequences of this ongoing health crisis. While COVID-19 may eventually become a manageable illness, its economic impact—like its health impact—will be felt for years to come.